Brexpiprazole
CAS 913611-97-9
Overview
Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic. It is a dopamine D₂ receptor partial agonist and has been described as a "serotonin–dopamine activity modulator"
Anant Labs manufacture and furnish high quality Brexpiprazole impurities for global markets. Our Brexpiprazole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-BRX-00
CAS913611-97-9
Mol. FormulaC25H27N3O2S
Mol. Weight433.57 g/mol
IUPAC7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
SMILESC1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4
InChIInChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)
InChI KeyZKIAIYBUSXZPLP-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
7-[4-(4-Benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)-quinolinoneBREXPIPRAZOLE913611-97-9RexultiOPC-34712OPC 34712brexpiprazol2J3YBM1K8C7-(4-(4-(1-Benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
